351 related articles for article (PubMed ID: 12049108)
1. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108
[TBL] [Abstract][Full Text] [Related]
2. Giant cell fibroblastoma associated with dermatofibrosarcoma protuberans: a case report.
Maeda T; Hirose T; Furuya K; Shirakawa K; Kobayashi K
Mod Pathol; 1998 May; 11(5):491-5. PubMed ID: 9619604
[TBL] [Abstract][Full Text] [Related]
3. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger.
Jha P; Moosavi C; Fanburg-Smith JC
Ann Diagn Pathol; 2007 Apr; 11(2):81-8. PubMed ID: 17349565
[TBL] [Abstract][Full Text] [Related]
4. Dermatofibrosarcoma protuberans recurring as a hybrid dermatofibrosarcoma/giant cell fibroblastoma in an adult: a case report.
Warbrick-Smith J; Hollowood K; Birch J
J Plast Reconstr Aesthet Surg; 2010 Nov; 63(11):e785-7. PubMed ID: 20655288
[TBL] [Abstract][Full Text] [Related]
5. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
6. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
[TBL] [Abstract][Full Text] [Related]
7. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity.
Diwan AH; Skelton HG; Horenstein MG; Kelly DR; Barrett TL; Bussian AH; Sanders DY; Lazar AJ; Prieto VG; Smith KJ
J Cutan Pathol; 2008 Jul; 35(7):647-50. PubMed ID: 18201229
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
11. [Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature].
Bisceglia M; Vairo M; Calonje E; Fletcher CD
Pathologica; 1997 Jun; 89(3):264-73. PubMed ID: 9380420
[TBL] [Abstract][Full Text] [Related]
12. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
Reimann JD; Fletcher CD
Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
[TBL] [Abstract][Full Text] [Related]
13. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
14. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype.
Silverman JS; Tamsen A
J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292
[TBL] [Abstract][Full Text] [Related]
15. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas.
Connelly JH; Evans HL
Am J Surg Pathol; 1992 Oct; 16(10):921-5. PubMed ID: 1415902
[TBL] [Abstract][Full Text] [Related]
16. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
18. Composite dermatofibrosarcoma protuberans-giant cell fibroblastoma recurring as Bednár tumor-giant cell fibroblastoma with mucoid lakes and with amputation neuroma.
Zámecník M; Michal M; Chlumská A
Cesk Patol; 2002 Oct; 38(4):173-7. PubMed ID: 12629865
[TBL] [Abstract][Full Text] [Related]
19. FNA diagnosis of giant cell fibroblastoma: a case report of an unusual pediatric soft tissue tumor.
Davis JL; Mathes E; Berry AB
Diagn Cytopathol; 2015 Apr; 43(4):325-8. PubMed ID: 25088682
[TBL] [Abstract][Full Text] [Related]
20. Giant-cell fibroblastoma and dermato fibro sarcoma protuberans: the same tumoral spectrum? Report of two cases of association in children.
Galinier P; Scheiner C; Bardot J; Vasse D; Rimareix F; Faissal T; Magalon G
Eur J Pediatr Surg; 2000 Dec; 10(6):390-4. PubMed ID: 11215782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
